BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rana D, Chawla YK, Duseja A, Dhiman R, Arora SK. Functional reconstitution of defective myeloid dendritic cells in chronic hepatitis C infection on successful antiviral treatment. Liver Int. 2012;32:1128-1137. [PMID: 22309109 DOI: 10.1111/j.1478-3231.2011.02754.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sachdeva M, Chawla YK, Arora SK. Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection. World J Hepatol 2015;7:2202-8. [PMID: 26380045 DOI: 10.4254/wjh.v7.i19.2202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
2 Shi J, Li Y, Chang W, Zhang X, Wang FS. Current progress in host innate and adaptive immunity against hepatitis C virus infection. Hepatol Int 2017;11:374-83. [PMID: 28643186 DOI: 10.1007/s12072-017-9805-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
3 Tomer S, Chawla YK, Duseja A, Arora SK. Dominating expression of negative regulatory factors downmodulates major histocompatibility complex Class-II expression on dendritic cells in chronic hepatitis C infection. World J Gastroenterol 2016;22:5173-82. [PMID: 27298560 DOI: 10.3748/wjg.v22.i22.5173] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Pereira GL, Tarragô AM, Neves WLL, da Silva Neto PV, de Souza PS, Dos Santos Affonso J, de Sousa KS, da Silva JA, Costa AG, da Silva Victoria F, Victoria MB, Malheiro A. Immunological Dynamics Associated with Direct-Acting Antiviral Therapies in Naive and Experimented HCV Chronic-Infected Patients. Mediators Inflamm 2019;2019:4738237. [PMID: 31780860 DOI: 10.1155/2019/4738237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Manickam C, Rajakumar P, Wachtman L, Kramer JA, Martinot AJ, Varner V, Giavedoni LD, Reeves RK. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection. J Virol 2016;90:9153-62. [PMID: 27489267 DOI: 10.1128/JVI.01051-16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Peng CY, Chen TH, Lim YP, Tsai FJ, Lin WY, Liao WL, Wan L. Association of MRC-1 and IL-28B with the treatment outcome of hepatitis C: a case control study. BMC Gastroenterol 2014;14:113. [PMID: 24969847 DOI: 10.1186/1471-230X-14-113] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
7 Tomer S, Arora SK. A juggernaut of innate & adaptive immune cells in chronic hepatitis C. Indian J Med Res 2020;151:279-86. [PMID: 32461391 DOI: 10.4103/ijmr.IJMR_1387_17] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ma YY, Yang MQ, Wang CF, Ding J, Li JY. Inhibiting mast cell degranulation by HO-1 affects dendritic cell maturation in vitro. Inflamm Res 2014;63:527-37. [PMID: 24604352 DOI: 10.1007/s00011-014-0722-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]